These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20024514)

  • 1. Melanocortin peptide therapy for the treatment of arthritic pathologies.
    Getting SJ; Kaneva M; Bhadresa Y; Renshaw D; Leoni G; Patel HB; Kerrigan MJ; Locke IC
    ScientificWorldJournal; 2009 Dec; 9():1394-414. PubMed ID: 20024514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting melanocortin receptors as potential novel therapeutics.
    Getting SJ
    Pharmacol Ther; 2006 Jul; 111(1):1-15. PubMed ID: 16488018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin 1 and melanocortin peptide therapy for protection against ischaemic-reperfusion damage in the heart.
    Gavins FN; Leoni G; Getting SJ
    ScientificWorldJournal; 2006 Aug; 6():1008-23. PubMed ID: 16937007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The melanocortin system in control of inflammation.
    Catania A; Lonati C; Sordi A; Carlin A; Leonardi P; Gatti S
    ScientificWorldJournal; 2010 Sep; 10():1840-53. PubMed ID: 20852827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocortins and cardiovascular regulation.
    Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
    Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.
    Grässel S; Opolka A; Anders S; Straub RH; Grifka J; Luger TA; Böhm M
    Arthritis Rheum; 2009 Oct; 60(10):3017-27. PubMed ID: 19790046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides.
    Tatro JB
    Neuroimmunomodulation; 1996; 3(5):259-84. PubMed ID: 9218248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-resolving and anti-arthritic properties of the MC
    Garrido-Mesa J; Thomas BL; Dodd J; Spana C; Perretti M; Montero-Melendez T
    Front Immunol; 2022; 13():1078678. PubMed ID: 36505403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-MSH modulates cell adhesion and inflammatory responses of synovial fibroblasts from osteoarthritis patients.
    Böhm M; Apel M; Lowin T; Lorenz J; Jenei-Lanzl Z; Capellino S; Dosoki H; Luger TA; Straub RH; Grässel S
    Biochem Pharmacol; 2016 Sep; 116():89-99. PubMed ID: 27396757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of melanocortin receptors in the regulation of gouty inflammation.
    Montero-Melendez T; Patel HB; Perretti M
    Curr Rheumatol Rep; 2011 Apr; 13(2):138-45. PubMed ID: 21243457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.
    Böhm M; Grässel S
    Endocr Rev; 2012 Aug; 33(4):623-51. PubMed ID: 22736674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Melanocortin peptides : Fundamentals, translational research, clinical dermatology, and future perspectives].
    Böhm M
    Hautarzt; 2020 Oct; 71(10):741-751. PubMed ID: 32880662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective actions of melanocortins: a therapeutic opportunity.
    Catania A
    Trends Neurosci; 2008 Jul; 31(7):353-60. PubMed ID: 18550183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH.
    Anderson EJ; Çakir I; Carrington SJ; Cone RD; Ghamari-Langroudi M; Gillyard T; Gimenez LE; Litt MJ
    J Mol Endocrinol; 2016 May; 56(4):T157-74. PubMed ID: 26939593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortin receptor type 3 as a potential target for anti-inflammatory therapy.
    Lam CW; Getting SJ
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):311-5. PubMed ID: 15379600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception.
    Starowicz K; Przewłocka B
    Life Sci; 2003 Jul; 73(7):823-47. PubMed ID: 12798410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
    Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortins and their receptors and antagonists.
    Voisey J; Carroll L; van Daal A
    Curr Drug Targets; 2003 Oct; 4(7):586-97. PubMed ID: 14535656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 60 YEARS OF POMC: Melanocortin receptors: evolution of ligand selectivity for melanocortin peptides.
    Dores RM; Liang L; Davis P; Thomas AL; Petko B
    J Mol Endocrinol; 2016 May; 56(4):T119-33. PubMed ID: 26792827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.